Back Pain Doctor
Lumbar Facet Joint Pain
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Facet joints help guide movement in the lumbar spine. They can become painful after overload, repetitive extension or rotation, degenerative change or altered movement patterns. Pain is often localised and mechanical, meaning it changes with position and activity.
There is no single examination test that proves facet joint pain. The diagnosis is usually clinical and probabilistic, based on the pattern of symptoms, examination findings and exclusion of other important causes.
Treatment focuses on improving the load tolerance of the back and surrounding tissues. That may include strengthening, graded return to activity, addressing hip and trunk mechanics, and reducing repeated aggravating positions while the area settles.
Common symptoms
- Localised low back pain, often one-sided
- Pain aggravated by extension, rotation or standing
- Pain that may refer into the buttock or upper thigh
- Stiffness after rest or difficulty finding a comfortable position
Commonly seen in
Evidence for twelve treatment options in lumbar facet joint pain
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Every high-quality guideline says the same thing. The American College of Physicians makes a strong recommendation that chronic low back pain be treated first with exercise and multidisciplinary rehabilitation rather than drugs or procedures (Qaseem, Ann Intern Med 2017). An overview of 15 primary-care guidelines found consistent agreement on education, staying active, exercise and reassurance, and on discouraging routine imaging (Oliveira, Eur Spine J 2018). For neck pain the strongest effects also belong to exercise, with strengthening of the neck and upper quadrant showing a moderate short-term effect (Sterling, J Clin Med 2019). Adding pain-science education to exercise improves pain, disability and fear of movement over exercise alone (Bonatesta, J Pain 2021).
Pairing reviewed 2026-09-02.
Where it fits
Understanding why the back hurts, and moving well, does more than anything injected. Imaging is used to answer a specific question, not as a starting point. Degenerative findings are near universal and frequently unrelated to the pain.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. No study in facet joint pain
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Searched 3 November 2026 (PubMed: trigger point injection, wet needling, dry needling or trigger point with facet joint, facet syndrome, zygapophyseal or sacroiliac, 43 records, plus a randomised-trial and systematic-review pass on injection of the piriformis, gluteal, quadratus lumborum and multifidus muscles, 35 records). No study has given trigger point injection or needling to people diagnosed with facet joint pain. In a 43-person trial in older people with chronic low back pain, trigger point injection relieved pain less than a nerve block at the back of the L4-5 segment for up to seven days (Miyakoshi, Joint Bone Spine 2007). In muscular low back pain the trials of trigger point injection disagree, and the largest, in 180 emergency patients, found no benefit over standard care (Lajeunesse, Ann Emerg Med 2025). An evidence review concluded that trigger point injections, like facet joint injections, have not clearly been shown to be effective for low back pain (van Tulder, Eur Spine J 2006). No trial of this row's dilute glucose in back muscle was found.
Pairing reviewed 2026-11-03.
Where it fits
Directed at a tender muscle band that reproduces part of your pain, alongside the loading work. Not a treatment for the joint, disc or nerve itself.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Diagnostic use, under X-ray
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Two separate questions were asked here, and both matter. On the injection: in a double-blind randomised trial, 28 people whose facet pain had been confirmed by dual comparative medial branch blocks received either corticosteroid or saline into the joint under X-ray, and the steroid made no difference to how many went on to need radiofrequency neurotomy (91% against 75%) or to how soon they needed it (Kennedy, Am J Phys Med Rehabil 2018). On the guidance: pooling seven studies, ultrasound-guided lumbar medial branch blocks were in the wrong place 11% of the time when checked against X-ray, and ultrasound-guided facet joint injections 13% of the time when checked against CT (Ashmore, Pain Rep 2022); in a learning-curve study, anaesthetists experienced in regional blocks reached the target in only 29 of 40 attempts, and the authors concluded ultrasound is not a satisfactory replacement for X-ray at this target (Putzu, Anesth Essays Res 2022). What the blocks are genuinely good for is diagnosis: twelve randomised trials support radiofrequency neurotomy of the medial branches where the diagnosis has first been confirmed by controlled blocks (Janapala, J Pain Res 2021).
Pairing reviewed 2026-09-17.
Where it fits
Not treated with an ultrasound-guided injection here, because ultrasound cannot reliably reach this target and the injection itself did not beat saline. Where the facet joints look like the source and pain is not settling, the useful step is referral for X-ray-guided diagnostic medial branch blocks, which answer whether radiofrequency neurotomy is worth doing. See the note on cortisone.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Evidence is for focused
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
The class-level claim that spinal shockwave evidence is limited and inconsistent no longer holds at this joint, but what has been tested is the focused device rather than this one. In 128 people whose facet pain was confirmed by medial branch block, high-energy focused shockwave beat sham with a 64.4% fall in pain at twelve months (Cohen's d 1.12), a 42.3% fall in Oswestry disability against 12.5% in the sham group, and resolution of bone marrow oedema on MRI in 58.8% of treated patients against none of the controls (Nedelka, Int J Surg 2025). Six published letters and comments have since questioned its methods and reporting, so this is not settled evidence, and the trial's own reason for choosing a focused device was depth of penetration, which is exactly what a radial pressure wave lacks. Meta-analyses showing short-term benefit from shockwave in low back pain are in non-specific back pain rather than facet-confirmed pain (22 studies, 1,749 patients: pain -1.14, 95% CI -1.47 to -0.80; Oswestry -6.01, -7.97 to -4.05) (Wu, Medicine 2023).
Pairing reviewed 2026-09-13.
Where it fits
For the tender paraspinal and gluteal muscle that usually accompanies facet pain, rather than for the joint. Where the facet joint itself is the target, focused shockwave is the form with a trial behind it.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Beat sham in one 128-person trial
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Searched 17 October 2026: shockwave, shock wave or ESWT with facet, zygapophyseal or zygapophysial joint pain (11 records, all read). There is one randomised trial, and it used this device. In 128 people whose facet pain was confirmed by medial branch block, five weekly sessions of high-energy focused shockwave (0.35 mJ/mm2) to the facet joints beat sham: pain fell 64.4% at twelve months (Cohen's d 1.12), Oswestry disability fell 42.3% against 12.5% with sham, and bone marrow oedema at the joint resolved on MRI in 58.8% of treated patients against none of the controls; no adverse effects were reported (Nedelka, Int J Surg 2025). It is a single-centre trial run partly from the lead author's private spine clinic, and six published letters and comments have questioned it: whether single or double diagnostic blocks were used, missing detail on randomisation, concealment and blinding, an effect size unusually large for a pain treatment, uncorrected multiple comparisons, and a sham that was not shown to block the energy (Sun, Int J Surg 2025; Zhang, Int J Surg 2026). The same group's earlier retrospective comparison of 62 people reported shockwave holding up better than facet steroid injection and slightly worse than radiofrequency neurotomy, without figures in the abstract (Nedelka, Neuro Endocrinol Lett 2014). No independent group has repeated the result.
Pairing reviewed 2026-10-17.
Where it fits
Worth discussing for confirmed facet joint pain that has not settled with a good rehabilitation program, as a non-invasive step before radiofrequency denervation. It is there to make the exercise program possible, not to replace it, and patients are told it rests on one trial that has not yet been repeated.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Cortisone trials split; no placebo arm
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
Five randomised trials were found, every one against a cortisone injection and none against a dummy injection, and they disagree. The largest, a double-blind trial of 76 people, found no difference in pain at three, six or twelve months: 6 people in the PRP group and 5 in the cortisone group had their pain halved at six months, a function score favoured PRP at three months only, and the authors concluded the results do not support PRP for facet joint pain (Geoffroy, Joint Bone Spine 2025). A trial of 59 found no difference in pain or disability to three months (Santos, Acta Ortop Bras 2026), and one of 30 found both groups improved, with PRP ahead only on an MRI measure of joint inflammation (Kotb, Saudi Med J 2022). Against that, a triple-blind trial across several centres, in 50 people whose facet pain was confirmed by two test injections, found that at six months more of the PRP group had a meaningful gain in function and had their pain halved, while average pain scores and satisfaction did not differ significantly (Cauchon, Interv Pain Med 2024), and in a trial of 46 the success rate after cortisone fell from 85% at one month to 20% at six months while it rose over time after PRP (Wu, Pain Pract 2017). Pooling ten trials at the facet and sacroiliac joints, 392 people, pain was lower with PRP than with cortisone by 1.3 points out of 10 at three months and 1.7 at six, with no significant difference in disability, and the authors call the evidence inconclusive (Alatefi, Pain Med 2026). Cortisone is a modest standard to match here: in the one saline-controlled trial at this joint it did not reduce or delay the need for nerve ablation (Kennedy, Am J Phys Med Rehabil 2018). Where the route is reported the injection went inside the joint, and the one trial that reports its guidance used X-ray.
Pairing reviewed 2026-10-11.
Where it fits
Offered here where the facet joints have been identified as the pain source and a proper rehabilitation program has not been enough on its own. The realistic expectation, said before any money changes hands, is a result about level with cortisone that may last longer: two trials found PRP ahead at six months and the largest found no difference. Its purpose is to make loading and rehabilitation more manageable, not to replace them.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Only trial found no benefit
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
Tested in one small randomised trial, which was negative. Thirty-eight people whose facet joint pain had been confirmed by a numbing block were randomised to 1 mL of 75% glucose injected into the facet joint or to conservative care alone. Both groups improved; the glucose group scored worse on pain (median 5 against 4 out of 10) and on disability at three months, there was no difference at six months, and the authors found no effect attributable to the glucose (Pereira Pires, Medicine 2023). The positive reports are uncontrolled: a retrospective series of 177 people with neck, mid-back or low back pain given 20% dextrose into the facet joint capsules and nearby ligaments, 91% of whom reported less pain at two months to two and a half years (Hooper, J Altern Complement Med 2004), and three people given 50% dextrose into the L4/5 and L5/S1 facet joints together with magnetic stimulation (Wu, J Pain Res 2024). An older double-blind trial of 79 people that injected a dextrose-glycerine-phenol solution into the low back ligaments and joint capsules favoured the injection at six months (30 of 39 against 21 of 40 improved by half; Klein, J Spinal Disord 1993), but it did not select facet pain and the solution was not plain dextrose. Serious harms after spinal prolotherapy are rare but recorded, including meningitis and spinal cord injury in a survey of practitioners (Dagenais, Arch Phys Med Rehabil 2006). PubMed searches on 16 October 2026 (prolotherapy, dextrose or hypertonic glucose with facet, zygapophysial or zygapophyseal, 18 records; then randomised-trial and systematic-review passes across low back pain) found no other trial at the facet joint.
Pairing reviewed 2026-10-16.
Where it fits
Prolotherapy can be discussed here, but the one controlled trial at the facet joint found no benefit and patients are told that before it is used. It is considered only where facet pain has been confirmed and a well-run strengthening and movement program has stalled, and it sits alongside that program rather than replacing it.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used here
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Searched PubMed for the same hyaluronic acid terms with facet or zygapophyseal and lumbar or low back (15 records; 3 trials and 3 reviews). No trial has compared it with a placebo injection. Two randomised trials compared it with cortisone in the facet joints: in 60 people, CT-guided weekly hyaluronic acid was no worse than triamcinolone, with somewhat more benefit at six months (Fuchs, J Vasc Interv Radiol 2005); in 30 people, a single hylan injection and triamcinolone did not differ at one, three or six months, and most of the hyaluronic acid group's early pain relief had faded by six months (Annaswamy, Am J Phys Med Rehabil 2018). Uncontrolled pilots point both ways: gains to six months, lost by twelve, in 15 people (DePalma, PM R 2009), and no improvement at six weeks in 13 (Cleary, J Spinal Disord Tech 2008). Widespread joint inflammation starting two days after a facet hylan injection has been reported once (Kocak, Am J Phys Med Rehabil 2018). A review of 18 studies and 1,496 people found hyaluronic acid no different from cortisone on pain or satisfaction, these facet injections overall of little short-term or no benefit, and PRP better than cortisone in the longer term (Ambrosio, Global Spine J 2022).
Pairing reviewed 2026-10-26.
Where it fits
Not offered for this problem. Medial branch blocks and radiofrequency denervation are the established route once the facet joints are confirmed as the source.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. One case report only
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
No trial of perineural injection in facet joint pain. Searching perineural injection, neural prolotherapy, subcutaneous dextrose and glucopuncture terms against the lumbar spine and the facet joints returns one facet-specific report: a 92-year-old woman with severe refractory back pain treated in an emergency department with ultrasound-guided 5% dextrose into the multifidus muscle, which the authors describe as novel in that setting (Rose, Am J Emerg Med 2025). That injection went into muscle rather than under the skin, and a single case cannot show cause. The randomised dextrose evidence in low back pain used a caudal epidural and did not separate out facet joint pain (Maniquis-Smigel, Anesth Pain Med 2016).
Pairing reviewed 2026-09-16.
Where it fits
Only where examination finds tender, hypersensitive skin over the affected segment. The nerve branches that carry facet joint pain run deep, so this treatment is not aimed at the joint itself.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
A search of hydrodissection against facet joint, zygapophyseal, medial branch and facet arthropathy found two records, neither a treatment study for facet pain: one was brachial plexus hydrodissection in the neck, the other an intraoperative surgical exposure technique. Hydrodissection separates a nerve from the tissue compressing it; it does not act on a painful facet joint.
Pairing reviewed 2026-09-06.
Where it fits
Not a treatment for the facet joint. It is relevant only if assessment also finds an entrapped nerve contributing to the pain. The superior cluneal nerve at the iliac crest is the usual one.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other back conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
Can MRI prove facet joint pain?
Is facet joint pain serious?
What helps facet joint pain?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment